Clinical Research Progress of GLP-1RA Drug Semaglutide
Semaglutide is a polypeptide hypoglycemic drug,it has stood out in its glucagon-like peptide-1 receptor agonist class because of its safety,wide indications,long half-life and other advantages,and has become a hot spot in clinical research.This article provided a reference for Semaglutide's clinical application and reasonable selection by analyzing its safety and introducing the research progress in various aspects such as hypoglycemic,cardiovascular protection and weight loss.
国家科技期刊平台
NSTL
万方数据
